New online program aims to ease cancer treatment side effects
NCT ID NCT07512726
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a web-based support program for people with colorectal cancer undergoing treatment. The program provided information and tips on physical, emotional, and daily-life challenges. Researchers measured whether it helped reduce symptoms and improve quality of life compared to standard care alone.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- web-based supportive care program
- What this could lead to
- If it works, this could provide an easy-to-access way to help colorectal cancer patients feel better and manage daily life during treatment.
- What could go wrong
- This was a very small study (24 people) testing a support program, not a drug. The results may not apply to everyone, and the program might not be effective for all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
24 people
The number who actually took part.
- Started
-
Aug 2025
- Finished
-
Jan 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Diagnosis of colon cancer and receiving cancer treatment (within the first 3 months of diagnosis) * Being 18 years of age or older * Being able to read, understand, and communicate in Turkish * Having internet access * Being able to use a smartphone or computer * Having access to a smartphone or computer * Voluntary participation in the study Exclusion Criteria: * Having a psychiatric illness * Having a disability that impairs cognitive functions * Refusing to participate in the study * Poor general health * Incompatibility between treatment appointments and the study's data collection schedule
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Colorectal (colon or rectal) cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Koç University Hospital
Istanbul, Istanbul, 34840, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a lab test tell which chemo works for colon cancer?
- Can MRI and computer models predict how well cancer drugs reach tumors?
- Gut bacteria may hold clues to why some cancer treatments work better
- Burning the edges: a new way to stop colon polyps from coming back
- Missed Follow-Up colonoscopies: do they raise the risk of advanced growths?
- A 2.2 mm scope could spot cancerous tissue in minutes, not days